| Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I–III nonsmall cell lung cancer K Kaira, N Oriuchi, H Imai, K Shimizu, N Yanagitani, N Sunaga, T Hisada, ... British journal of cancer 98 (4), 742-748, 2008 | 244 | 2008 |
| Resolvin E1 dampens airway inflammation and hyperresponsiveness in a murine model of asthma H Aoki, T Hisada, T Ishizuka, M Utsugi, T Kawata, Y Shimizu, F Okajima, ... Biochemical and biophysical research communications 367 (2), 509-515, 2008 | 200 | 2008 |
| Metabolic activity by 18F–FDG-PET/CT is predictive of early response after nivolumab in previously treated NSCLC K Kaira, T Higuchi, I Naruse, Y Arisaka, A Tokue, B Altan, S Suda, A Mogi, ... European journal of nuclear medicine and molecular imaging 45, 56-66, 2018 | 190 | 2018 |
| l‐type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms K Kaira, N Oriuchi, H Imai, K Shimizu, N Yanagitani, N Sunaga, T Hisada, ... Cancer science 99 (12), 2380-2386, 2008 | 180 | 2008 |
| Usefulness of FDG-PET for early prediction of the response to gefitinib in non-small cell lung cancer N Sunaga, N Oriuchi, K Kaira, N Yanagitani, Y Tomizawa, T Hisada, ... Lung cancer 59 (2), 203-210, 2008 | 162 | 2008 |
| Diagnostic Usefulness of Fluorine–18-α–Methyltyrosine Positron Emission Tomography in Combination With 18F-Fluorodeoxyglucose in Sarcoidosis Patients K Kaira, N Oriuchi, Y Otani, N Yanagitani, N Sunaga, T Hisada, T Ishizuka, ... Chest 131 (4), 1019-1027, 2007 | 156 | 2007 |
| Phase II prospective study of the efficacy of gefitinib for the treatment of stage III/IV non-small cell lung cancer with EGFR mutations, irrespective of previous chemotherapy N Sunaga, Y Tomizawa, N Yanagitani, H Iijima, K Kaira, K Shimizu, ... Lung Cancer 56 (3), 383-389, 2007 | 141 | 2007 |
| Roles of cyclic AMP response element binding activation in the ERK1/2 and p38 MAPK signalling pathway in central nervous system, cardiovascular system, osteoclast … Y Koga, H Tsurumaki, H Aoki-Saito, M Sato, M Yatomi, K Takehara, ... International journal of molecular sciences 20 (6), 1346, 2019 | 136 | 2019 |
| Fluorine-18-α-methyltyrosine positron emission tomography for diagnosis and staging of lung cancer: a clinicopathologic study K Kaira, N Oriuchi, Y Otani, K Shimizu, S Tanaka, H Imai, N Yanagitani, ... Clinical Cancer Research 13 (21), 6369-6378, 2007 | 128 | 2007 |
| Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in stage I pulmonary adenocarcinoma K Kaira, N Oriuchi, H Imai, K Shimizu, N Yanagitani, N Sunaga, T Hisada, ... Lung cancer 66 (1), 120-126, 2009 | 121 | 2009 |
| Extracellular acidification stimulates IL-6 production and Ca2+ mobilization through proton-sensing OGR1 receptors in human airway smooth muscle cells I Ichimonji, H Tomura, C Mogi, K Sato, H Aoki, T Hisada, K Dobashi, ... American Journal of Physiology-Lung Cellular and Molecular Physiology 299 (4 …, 2010 | 120 | 2010 |
| Glutathione redox regulates airway hyperresponsiveness and airway inflammation in mice Y Koike, T Hisada, M Utsugi, T Ishizuka, Y Shimizu, A Ono, Y Murata, ... American journal of respiratory cell and molecular biology 37 (3), 322-329, 2007 | 112 | 2007 |
| Glucocorticoids reverse IL‐1β‐induced impairment of β‐adrenoceptor‐mediated relaxation and up‐regulation of G‐protein‐coupled receptor kinases JCW Mak, T Hisada, M Salmon, PJ Barnes, KF Chung British journal of pharmacology 135 (4), 987-996, 2002 | 107 | 2002 |
| CD98 expression is associated with poor prognosis in resected non-small-cell lung cancer with lymph node metastases K Kaira, N Oriuchi, H Imai, K Shimizu, N Yanagitani, N Sunaga, T Hisada, ... Annals of surgical oncology 16, 3473-3481, 2009 | 104 | 2009 |
| Protective effect of resolvin E1 on the development of asthmatic airway inflammation H Aoki, T Hisada, T Ishizuka, M Utsugi, A Ono, Y Koga, N Sunaga, ... Biochemical and biophysical research communications 400 (1), 128-133, 2010 | 96 | 2010 |
| Mechanism of gastroesophageal reflux in patients with obstructive sleep apnea syndrome S Kuribayashi, M Kusano, O Kawamura, Y Shimoyama, M Maeda, ... Neurogastroenterology & Motility 22 (6), 611-e172, 2010 | 91 | 2010 |
| Evidence of oxidative stress in asthma and COPD: potential inhibitory effect of theophylline H Tsukagoshi, Y Shimizu, S Iwamae, T Hisada, T Ishizuka, K Iizuka, ... Respiratory medicine 94 (6), 584-588, 2000 | 87 | 2000 |
| Expression of L-type amino acid transporter 1 (LAT1) in neuroendocrine tumors of the lung K Kaira, N Oriuchi, H Imai, K Shimizu, N Yanagitani, N Sunaga, T Hisada, ... Pathology-Research and Practice 204 (8), 553-561, 2008 | 81 | 2008 |
| Correlation of angiogenesis with 18F‐FMT and 18F‐FDG uptake in non‐small cell lung cancer K Kaira, N Oriuchi, K Shimizu, T Ishikita, T Higuchi, H Imai, N Yanagitani, ... Cancer science 100 (4), 753-758, 2009 | 74 | 2009 |
| Atrial natriuretic peptide inhibits tumor necrosis factor-alpha production by interferon-gamma-activated macrophages via suppression of p38 mitogen-activated protein kinase and … H Tsukagoshi, Y Shimizu, T Kawata, T Hisada, Y Shimizu, S Iwamae, ... Regulatory peptides 99 (1), 21-29, 2001 | 73 | 2001 |
